PRN: Global Markets for Stem Cells and Stem Cell Products Expected to Reach $6.6 Billion by 2016

10/lug/2012 21.42.14 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Markets for Stem Cells and Stem Cell Products Expected to Reach $6.6 Billion by 2016

 
[10-July-2012]
 

DALLAS, July 10, 2012 /PRNewswire/ -- ReportsnReports.com adds a new market research report "Global Markets for Stem Cells" to its store. The highlights of this stem cells report includes:

  • The global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $4.3 billion in 2012 and $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016.
  • The American market for stem cell products was $1.3 billion in 2011. This sector is expected to rise at a CAGR of 11.5% and reach nearly $2.3 billion by 2016.
  • The European market for stem cell products was $872 million in 2011 and is expected to reach nearly $1.5 billion by 2016, a CAGR of 10.9%.

The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription drug products. Important trends are ide! ntified and sales forecasts by product categories and major country markets are provided through 2016; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the stem cell-related drug market.  The wider economic environment is also taken into account.

The report examines strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market.

SCOPE OF REPORT

This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets.  The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed with profiles of the leading companies, including recent M&A activity.  Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

MARKET ANALYSES AND FORECASTS

Market figures are based on revenues at the manufacturer level and are projected at 2012-dollar value without attempting to predict the effect of inflation/deflation. Therapeutic categories quantified and forecast include cancer, CNS diseases, infections and cardiovascular.  Major country markets in three regionsâ€�”Americas, Europe and Asiaâ€�”are analyzed and forecast, with a summary for the rest of the world.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. Primary research includes interviews with leading individuals in stem cell companies and industry associations. Primary sources of published data include company annual reports, SEC filings, and government and industry publications.  Secondary sources consist of literature searches, industry journals and other commercial publications.  Data for market estimates and forecasts are pooled from a range of sources, critically assessed by BCC.

INTENDED AUDIENCE

This report is designed to satisfy the information needs of a wide variety of individuals involved in the pharmaceutical marketplace, including company senior management executives seeking to base their strategic decisions on the best available information on market forces and trends.  However it is also aimed at managers and executives in marketing, research, planning and sales departments who need readable, comprehensive and up-to-date background on the marketplace in which they are operating.

INFORMATION SOURCES

Sources of information included marketing strategists, industry executives, government agencies and regulatory bodies, and surveys of physicians and pharmacists.  Company annual reports and SEC filings, journal articles, and data from healthcare institutions were also reviewed.

Request A Sample, Inquire before Buying OR Buy your copy of this report @ http://www.reportsnreports.com/reports/174246-global-markets-for-stem-cells.html

Table of Contents for this report cover:

Chapter 1 Introduction 1
Study Goals And Objectives 1
Reasons For Doing The Study 1
Scope Of Report 1
Market Analyses And Forecasts 1
Methodology 1
Intended Audience 2
Information Sources 2
Analyst Credentials 2
Related Reports 2
Bcc Online Services 2
Disclaimer 3

Chapter 2 Summary 5
Definitions 5
Applications 5
Research And Commercialization 5
Funding 6
Market 6
Summary Table Global Stem Cell Market And Forecasts, Through 2016 ($ Millions) 7
Summary Figure Global Stem Cell Market And Forecasts, 2010-2016 ($ Millions) 7

Chapter 3 Overview 9
Cells 9
Stem Cells 9
Figure 1 Early Development Of Embryo 9
Induced Pluripotent Stem Cells 12
Hpscs 13
The Cancer Problem 14
Cancer Stem Cells - A Wider Topic 14

Chapter 4 Stem Cell Research 18
History 18
Embryonic Stem Cells 19
Growth And Identification Of Escs 19
Stimulating Escs To Differentiate 20
Adult Stem Cells 20
Mesenchymal Stem Cells (Mscs) 20
Haematopoietic Stem Cells (Hscs) 21
Neural Stem Cell (Nsc) 21
Endothelial Progenitor Cell (Epc) 21
Epithelial Stem Cell (Esc) 21
Very Small Embryonic-Like Cell (Vsel) 21
Cord Blood Stem Cells 21
Induced Pluripotent Stem Cells (Ipscs) 22
Nuclear Reprogramming 22
Cell-Based Therapeutics 23
Embryonic-Derived Stem Cells 23
Adult/Progenitor-Derived Stem Cells 23
Engineered Scs For Transplantation 24
Therapeutic Stem Cell Banking 24
Stem Cell-Based Biomedical Research 25
Stem Cell Research Centers 25
Regulation Of Stem Cell Research 27
Australia 27
Brazil 27
Canada 28
China 28
France 28
Germany 29
India 29
Ireland 29
Israel 29
Italy 29
Japan 30
South Korea 30
Spain 30
Sweden 31
United Kingdom 31
United States 31
California 31
Massachusetts 31
Michigan 31
New Jersey 32
New York 32
European Union 32
Practicalities Of Stem Cell Research And Production 33
Stem Cell Production 33
Stem Cell ! Acquisition 33
Characterization And Expansion 33
Maint! enance A nd Storage 34
Stem Cell Production Economics 35
Customized Therapy 35
Banks 36
Novel Stem Cell Production Developments 36
Isolation And Engineering 37
Adult Stem Cells 37
Embryonic Stem Cells 38
Induced Pluripotent Stem Cells 39
Stem Cell Banking 39
Table 1 Countries Engaged In The Iscbi Program 40

Chapter 5 Stem Cell Applications 43
Regenerative Medicine 43
Current Applications Of Stem Cell Therapy 45
Cancer 45
Hematopoiesis (Blood Cell Formation) 45
Amyotrophic Lateral Sclerosis 46
Parkinson's Disease 47
Spinal Cord Injury 48
Alzheimer's Disease 49
Heart Disease 50
Peripheral Arterial Disease 52
Type 1 Diabetes 54
Orthopedic Repair 55
Liver Failure 55
Graft-Versus-Host Disease 56
Lung Disease 57

Chapter 6 Stem Cell Patents 59
General Background On Patents 59
Stem Cell Patents 59
Patentability Of Stem Cell Lines 60
Individual Country Policies 60
United States 60
Canada 61
Epc 61
United Kingdom 61
Germany 61
Japan 62
China 62
Ips Cells 62
Table 2 Ips-Related Patents (Yamanaka, 2011) 62
Table 3 Classification Of Stem Cell Patents 64

Chapter 7 Stem Cell Markets 66
Markets For Stem Cells 66
Market Drivers 66
Healthcare 66
Table 4 Healthcare Systems Of Different Countries 67
Biotechnology 69
Pharmaceutical 69
Market Opportunities By Therapeutic Class 70
Cancer 70
Other Cancers 71
Cardiovascular Disease 72
Myocardial Infarction 73
Table 5 Examples Of Companies Developing Stem Cell Therapies For Cvd 73
Central Nervous System Disease 74
Spinal Cord Injury (Sci) 74
Table 6 Statistics For Sci Worldwide, 2011 75
Neurodegenerative Diseases 76
Table 7 Neurodegenerative Diseases Worldwide, 2011 (Millions) 76
Diabetes Mellitus 77
Table 8 Statistics For Diabetes In The U.S., 2010 77
Table 9 Global Market For Diabetes Mellitus, Treatments And Devices, Through 2016 ($ Billions) 77
Skeletal System 78
Global Market Estimates And Forecasts 79
Table 10 Global Stem Cell Market, Through 2016 ($ Millions) 79
Regional And ! National Market Analysis 79
Americas 79
Table 11 Stem Cell Market: Americas, Historic And Forecast Data, Through 2016 ($ Millions) 79
U.S. 80
Table 12 Potential U.S. Patient Populations For Cell-Based Therapies 80
Table 13 U.S. Stem Cell Therapy Market: Historic And Forecast Data, Through 2016 ($ Millions) 81
Table 14 U.S. Stem Cell Research And Services Market: Historic And Forecast Data, Through 2016 ($ Millions) 81
Table 15 U.S. Stem Cell Cord Blood Services Market: Historic And Forecast Data, Through 2016 ($ Millions) 82
Canada 82
Table 16 Canadian Stem Cell Therapy Market: Historic And Forecast Data, Through 2016 ($ Millions) 83
Table 17 Canadian Stem Cell Research And Services Market: Historic And Forecast Data, Through 2016 ($ Millions) 83
Table 18 Canadian Stem Cell Cord Blood Services Market: Historic And Forecast Data, Through 2016 ($ Millions) 83
Brazil 83
Table 19 Brazil Stem Cell Therapy Market: Historic A! nd Forec ast Data, Through 2016 ($ Millions) 84
Table 20 Brazil Stem Cell Research And Services Market: Historic And Forecast Data, Through 2016 ($ Millions) 85
Table 21 Brazil Stem Cell Cord Blood Services Market: Historic And Forecast Data, Through 2016 ($ Millions) 85
Mexico 85
Table 22 Mexico Stem Cell Therapy Market: Historic And Forecast Data, Through 2016 ($ Millions) 86
Table 23 Mexico Stem Cell Cord Blood Services Market: Historic And Forecast Data, Through 2016 ($ Millions) 86
Europe 86
Table 24 Stem Cell Market: Europe, Historic And Forecast Data, Through 2016 ($ Millions) 86
Market Opportunities By Disease Category 87
Table 25 Statistics For Cvd In Europe, 2011 87
Table 26 Rate Of Death From Heart Disease In Different European Countries, 2011 (No. Of Deaths Per 100,000 Cases) 88
Table 27 Statistics For Cns Disorders And Injuries In! Europe, 2011 88
Table 28 Statistics For Sci And Parkinson's Disease In Different European Countries, 2011 89
Table 29 Prevalence Of Diabetic Patients In Different European Countries, 2010 89
France 89
Table 30 Stem Cell Therapy Market In France: Historic And Forecast Data, Through 2016 ($ Millions) 90
Table 31 Stem Cell Research And Services Market In France: Historic And Forecast Data, Through 2016 ($ Millions) 90
Table 32 Stem Cell Cord Blood Services Market In France: Historic And Forecast Data, Through 2016 ($ Millions) 90
Germany 90
Table 33 Stem Cell Therapy Market In Germany: Historic And Forecast Data, Through 2016 ($ Millions) 91
Table 34 Stem Cell Research And Services Market In Germany: Historic ! And Forecast Data, Through 2016 ($ Millions) 91
Table 35 S! tem Cell Cord Blood Services Market In Germany: Historic And Forecast Data, Through 2016 ($ Millions) 91
Italy 91
Table 36 Stem Cell Therapy Market In Italy: Historic And Forecast Data, Through 2016 ($ Millions) 92
Table 37 Stem Cell Research And Services Market In Italy: Historic And Forecast Data, Through 2016 ($ Millions) 93
Table 38 Stem Cell Cord Blood Services Market In Italy: Historic And Forecast Data, Through 2016 ($ Millions) 93
Spain 93
Table 39 Stem Cell Therapy Market In Spain: Historic And Forecast Data, Through 2016 ($ Millions) 94
Table 40 Stem Cell Research And Services Market In Spain: Historic And Forecast Data, Through 2016 ($ Millions) 94
Table 41 Stem Cell Cord Blood Ser! vices Market In Spain: Historic And Forecast Data, Through 2016 ($ Millions) 95
United Kingdom 95
Table 42 Stem Cell Therapy Market In U.K.: Historic And Forecast Data, Through 2016 ($ Millions) 96
Table 43 Stem Cell Research And Services Market In U.K.: Historic And Forecast Data, Through 2016 ($ Millions) 96
Table 44 Stem Cell Cord Blood Services Market In U.K.: Historic And Forecast Data, Through 2016 ($ Millions) 96
Asia 96
Market Opportunities By Disease Category 96
Table 45 Statistics For Cvd In Different Regions Of The World, 2011 96
Table 46 Examples Of Stem Cell Policies In Asian Countries 97
Table 47 Stem Cell Market: Asia, Historic And Forecast Data, Through 2016 ($ Millions) 98
Japan 98
Table 48 Stem Cell Therapy Market In Japan: Historic And Forecast Data, Through 2016 ($ Millions) 99!
Tab le 49 Stem Cell Research And Services Market In Japan: Historic And Forecast Data, Through 2016 ($ Millions) 99
Table 50 Stem Cell Cord Blood Services Market In Japan: Historic And Forecast Data, Through 2016 ($ Millions) 99
China 100
Table 51 Stem Cell Therapy Market In China: Historic And Forecast Data, Through 2016 ($ Millions) 102
Table 52 Stem Cell Research And Services Market In China: Historic And Forecast Data, Through 2016 ($ Millions) 102
Table 53 Stem Cell Cord Blood Services Market In China: Historic And Forecast Data, Through 2016 ($ Millions) 102
India 103
Table 54 Potential Candidates For Stem Cell Therapy In India 103
Table 55 Stem Cell Therapy Market In India: Historic And Forecast Data, Through 2016 ($ Millions) 104
Table 56 Stem Cell Research And Services Market In India: Historic And Forecast Data, Through 2016 ($ Millions) 104
Table 57 Stem Cell Cord Blood Services Market In India: Historic And Forecast Data, Through 2016 ($ Millions) 105
Rest Of World 105
Table 58 Stem Cell Market In Row: Historic And Forecast Data, Through 2016 ($ Millions) 105

Chapter 8 Company Profiles 107
3dm 107
Aastrom Biosciences, Inc. 108
Advanced Cell Technology, Inc. 108
Aldagen, Inc. 109
Angioblast Systems 109
Arteriocyte 110
Athersys Inc. 110
Beike Biotechnology Co., Ltd. 111
Bioe 111
Bioheart, Inc. 112
Biotime, Inc. 112
Brainstorm Cell Therapeutics Inc. 113
Capricor, Inc. 114
Cardio3 Biosciences 114
Cellartis Ab 115
Cellerant Therapeutics, Inc. 116
Cellerix Sa 116
Cellular Dynamics International 117
Cytori Therapeutics, Inc. 117
Epistem Ltd. 118
Forticell Bioscience, Inc. 119
Gamida Cell, Ltd. 119
Globalstem 119
Hybrid Organ Gmbh 120
Intellicell Biosciences, Inc. 120
International Stem Cell Corporation 121
Juventas Therapeutics, Inc. 122
Medistem Inc. 122
Mesoblast Ltd. 123
Neostem, Inc. 123
Neuralstem 124
Neurogeneration 124
Osiris Therapeutics, Inc. 125
Pharmastem Therapeutics, Inc. 126
! Plureon Corporation 126
Primegen Biotech, Llc 126
Reneuron Group 127
Rhinocyte Inc. 127
Stem Cells Inc. 128
Stemcell Technologies Sarl 128
Stem Cell Therapeutics Corp. 129
Stemedica Cell Technologies, Inc. 130
Stemina Biomarker Discovery Inc. 131
Stempeutics Research Pvt. Ltd. 131
Tigenix Nv 132
Tristem Corporation 133
Verastem, Inc. 133
Veristem Technologies 134
Viacyte 135
Vitro Diagnostics, Inc. 135
Wicell Research Institute 136
Xpand Biotechnology Bv 136

Chapter 9 Appendix 1: Glossary 139

Chapter 10 Appendix 2: Significant Stem Cell Research Patents 145
Table 59 Significant Stem Cell Research Patents 145

List Of Tables (59 Tables)

List Of Figures (2 Figures)

Explore more reports on:


Find newly published market research reports for other industries @ http://www.reportsnreports.com/latest-market-research.aspx.

About Us:

ReportsnReports.com (http://www.reportsnreports.com/) is an online market research reports library of 175,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Contact:

Priyank Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441
sales@reportsandreports.com
Explore Company Profiles, SWOT Analysis Reports, Micro Markets & Country specific reports @ http://www.marketreportsonline.com/.

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl